Neil R. Norcross - Concepedia

Concepedia

Author

Neil R. Norcross

University of Dundee ORCID

Also Known As

N. Norcross, Neil Norcross, Neil R Norcross, Neil R. Norcross, Norcross, N.R., O.G. Raimi, Zoe C. Johnston

36

Publications

1.3K

Citations

15

H-Index

28

Concepts

All Affiliations

University of Dundee Swiss Tropical and Public Health Institute Medicines for Malaria Venture University of Basel University of California San Diego

NR

About

Neil R. Norcross is an author at University of Dundee specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	610
2	Natural Sciences	3	3	148
3	Biochemistry	3	3	84
4	Business	1	1	34
5	Management	1	1	34

Neil R. Norcross

×

18

Publications

1.3K

Citations

15

H-Index

	Year	Citations
A novel multiple-stage antimalarial agent that inhibits protein synthesis Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross, Nature Antiparasitic AgentMedicineMalariaPharmacologyProtein Synthesis	2015	452
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis Beatriz Baragaña, Barbara Forte, Ryan Choi, Proceedings of the National Academy of Sciences	2019	132
Discovery of a Novel Class of Orally Active Trypanocidal <i>N</i>-Myristoyltransferase Inhibitors Stephen Brand, Laura A. T. Cleghorn, Stuart P. McElroy, Journal of Medicinal Chemistry	2011	115
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy Beatriz Baragaña, Neil R. Norcross, Caroline Wilson, Journal of Medicinal Chemistry	2016	89
Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis Hari Babu Tatipaka, J. Robert Gillespie, Arnab K. Chatterjee, Journal of Medicinal Chemistry Bioorganic ChemistryAntiparasitic AgentPharmacotherapyCompound LibraryPharmaceutical Chemistry	2013	74
Lead Optimization of a Pyrazole Sulfonamide Series of <i>Trypanosoma brucei</i> <i>N</i> -Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis Stephen Brand, Neil R. Norcross, Stephen Thompson, Journal of Medicinal Chemistry	2014	72
Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design J.C. Pizarro, T. Hills, Guillermo Senisterra, PLoS neglected tropical diseases Drug TargetAntiparasitic AgentMolecular BiologyChemical BiologyMedicinal Chemistry	2013	56
Identification of Inhibitors of the <i>Leishmania</i> cdc2‐Related Protein Kinase CRK3 Laura A. T. Cleghorn, Andrew Woodland, Iain T. Collie, ChemMedChem	2011	47
Total Synthesis of (±)-α-Isosparteine, (±)-β-Isosparteine, and (±)-Sparteine from a Common Tetraoxobispidine Intermediate Neil R. Norcross, J.P. Melbardis, M.F. Solera, The Journal of Organic Chemistry	2008	43
Managing Change: Analysis of a Hypothetical Case Joan S. Ash, James G. Anderson, Paul Gorman, Journal of the American Medical Informatics Association Public PolicyChange Management (Itsm)Change ManagementManagementBusiness	2000	34

Page 1